Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
about
AR, apoE, and cognitive functionMagnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopySmall-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathologyImaging genetics of structural brain connectivity and neural integrity markers.Global N-acetylaspartate declines even in benign multiple sclerosisThe immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.New approaches to investigating heterogeneity in complex traitsMultiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.Multiple sclerosis genetics: leaving no stone unturned.Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells.Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review.Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
P2860
Q24646534-FBC2A162-E5DC-459B-B0DA-A7599EAE8D43Q24800569-4F2DD63C-6B0A-4796-8645-C689784C30AFQ30421643-2B5F092F-02E0-40E4-9D6A-CDEAF4242575Q33516442-8CC350E7-DE07-4AE0-B471-71653612A102Q33725131-38EA87E2-5BFB-4AEB-B431-7D49AA19E333Q33960847-DFC53A2E-FD03-40D2-95C3-CB3500603AEEQ35200318-C3359D62-9099-4ECE-8F34-41D0FFC0C33DQ35629319-AEF7B7C5-5E5F-4A56-8F79-99634D794F7FQ36171871-BC1BCF03-24EE-42FA-ADAE-5E5E1979A455Q36212078-38DD5F00-6874-442A-A684-817F1A65D3FBQ38782456-46D4BF98-667D-4564-9951-2A9A3B1E5E6BQ46912034-0A8F36D0-5CD0-4C20-A6D9-71AB58951D2AQ47932285-10E6A3DF-CC1E-481A-8569-5548A07660C5Q49834512-FEE69FE4-3E52-46F8-8677-BA81366BF3D3Q51766967-213D3D3E-FC57-433B-BEAC-860AE6813DD9
P2860
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@en
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@nl
type
label
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@en
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@nl
prefLabel
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@en
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@nl
P2093
P356
P1433
P1476
Lower levels of N-acetylaspart ...... lipoprotein E epsilon4 allele.
@en
P2093
Birgit Poltrum
Christian Enzinger
Helena Schmidt
Peter Kapeller
Reinhold Schmidt
Siegrid Strasser-Fuchs
Stefan Ropele
P356
10.1001/ARCHNEUR.60.1.65
P577
2003-01-01T00:00:00Z